Bulletin
Investor Alert

London Markets Open in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 8, 2023, 3:51 p.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.82

Change

-0.02 -1.09%

Volume

Volume 14,008

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.84

$ 1.82

Change

-0.02 -1.09%

Day low

Day high

$1.82

$1.85

Open

52 week low

52 week high

$0.88

$3.45

Open

Benoit Gravel

Benoit Gravel is on the board of Medexus Pharmaceuticals, Inc. and Member-Healthcare Council at Gerson Lehman Group (Asia) Ltd.

In his past career Mr. Gravel was Vice President-Global Portfolio Management at Zentiva Group AS, Chairman for The Public Sector Pension Investment Board, Vice President-Commercial Affairs at Aventis Pasteur Ltd., Director-Corporate Planning & Business Development at Rhone-Poulenc Canada, Inc. and VP-Diabetes & Specialized Care Unit at Sanofi Canada, Inc.

He received an undergraduate degree and a graduate degree from the University of Montréal.

Transactions

Date Shares Transaction Value
11/18/2022 25,847   0
12/19/2018 233,333   0
12/19/2018 233,333   0
10/16/2018 100,000   34,000
10/16/2018 100,000   34,000

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.